Effective preclinical drug development hinges on the deployment of robust in vivo models that accurately recapitulate human disease and response to therapy. Optimizing these models involves a multifaceted approach, https://saadzaws972170.blog5.net/75985369/tailoring-in-vivo-models-for-preclinical-drug-development